Geneos Therapeutics: Geneos Therapeutics Closes $5M Series A3 Financing

Geneos Therapeutics, a Plymouth Meeting, PA-based clinical stage biotherapeutics company, raised $5M in Series A 3 funding. The round, which brought the total amount to $10M, saw participation form Shanghai Healthcare Capital. Dr. Jing Bao, partner of SHC, will join as a board observer, bringing extensive expertise in the pharmaceutical industry and with global clinical trials. Led [...]The post Geneos Therapeutics Closes $5M Series A3 Financing appeared first on FinSMEs.